Visual and anatomical failure of anti-VEGF therapy for retinal vascular diseases: a survival analysis of real-world data
Real-world data suggest that undesirable events following anti-VEGF injections is likely to in 50% of patients by the third year of treatment in spite of appropriate loading. The definition of undesirable treatment events captured nearly all patients who were escalated to another therapy, but this proportion represented a small percentage of our definition of failed response.
Authors
- Konstantinos Balaskas (ORCID: https://orcid.org/0000-0003-2886-6896)
- Chrystie Wan Ning Quek
- Dun Jack Fu (ORCID: https://orcid.org/0000-0003-2852-6912)
- Livia Faes (ORCID: https://orcid.org/0000-0002-4159-3960)
- Amit V. Mishra (ORCID: https://orcid.org/0009-0006-7586-0154)
- Sobha Sivaprasad (ORCID: https://orcid.org/0000-0001-8952-0659)
- Nikolas Pontikos (ORCID: https://orcid.org/0000-0003-1782-4711)
- Dawn A. Sim (ORCID: https://orcid.org/0000-0002-6363-7805)
Institutions
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- King's College - North Carolina (US)
- National University of Singapore (SG)
- King's College London (GB)
- University College London (GB)
Publication Details
- Journal
- Eye
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1038/s41433-024-03529-9
- Citations
- 5
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.69